TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE
6.1. Overview
6.2. Functional Magnetic Resonance Imaging (FMRI)
6.3. Compound Tomography (CT)
6.4. Positron Emission Tomography (PET)
6.5. Electroencephalography (EEG)
6.6. Magnetoencephalography (MEG)
6.7. Near Infrared Spectroscopy (NIRS)
7. GLOBAL BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER
7.1. Overview
7.2. Hospitals
7.3. Ambulatory Surgical Centers
7.4. Clinics and Diagnostic Centers
8. GLOBAL BRAIN IMAGING AND NEUROIMAGING MARKET, BY REGION
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. South Korea
8.4.5. Australia
8.4.6. Rest of Asia-Pacific
8.5. Rest of the World
8.5.1. Middle East
8.5.2. Africa
8.5.3. Latin America
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Brain imaging and neuroimaging Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Brain imaging and neuroimaging Market,
9.7. Key developments and Growth Strategies
9.7.1. New IMAGING TYPE Launch/End User Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2022
9.8.2. Major Players R&D Expenditure. 2022
10. COMPANY PROFILES
10.1. GE
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Imaging Type Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Siemens
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Imaging Type Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Canon
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Imaging Type Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Hitachi Medical Systems
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Imaging Type Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Medtronic PLC.
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Imaging Type Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. EB Neuro S.p.A.
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Imaging Type Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Neurosoft
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Imaging Type Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. MinFound Medical Systems Co. Ltd.
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Imaging Type Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Elekta
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Imaging Type Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Varian medical Systems
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Imaging Type Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. General Electric Company
10.11.1. Company Overview
10.11.2. Financial Overview
10.11.3. Imaging Type Offered
10.11.4. Key Developments
10.11.5. SWOT Analysis
10.11.6. Key Strategies
10.12. Philips Healthcare
10.12.1. Company Overview
10.12.2. Financial Overview
10.12.3. Imaging Type Offered
10.12.4. Key Developments
10.12.5. SWOT Analysis
10.12.6. Key Strategies
10.13. Toshiba Medical Systems
10.13.1. Company Overview
10.13.2. Financial Overview
10.13.3. Imaging Type Offered
10.13.4. Key Developments
10.13.5. SWOT Analysis
10.13.6. Key Strategies
10.14. Sanrad medical Systems Pvt. Ltd
10.14.1. Company Overview
10.14.2. Financial Overview
10.14.3. Imaging Type Offered
10.14.4. Key Developments
10.14.5. SWOT Analysis
10.14.6. Key Strategies
10.15. Esaote SpA
10.15.1. Company Overview
10.15.2. Financial Overview
10.15.3. Imaging Type Offered
10.15.4. Key Developments
10.15.5. SWOT Analysis
10.15.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL BRAIN IMAGING AND NEUROIMAGING MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL BRAIN IMAGING AND NEUROIMAGING MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 5 NORTH AMERICA BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA BRAIN IMAGING AND NEUROIMAGING MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 8 U.S. BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 9 U.S. BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 10 CANADA BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 11 CANADA BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 12 EUROPE BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 13 EUROPE BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 14 EUROPE BRAIN IMAGING AND NEUROIMAGING MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 15 GERMANY BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 16 GERMANY BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 17 FRANCE BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 18 FRANCE BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 19 ITALY BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 20 ITALY BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 21 SPAIN BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 22 SPAIN BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 23 U.K BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 24 U.K BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 25 REST OF EUROPE BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 26 REST OF EUROPE BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 27 ASIA PACIFIC BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 28 ASIA PACIFIC BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 29 ASIA PACIFIC BRAIN IMAGING AND NEUROIMAGING MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 30 JAPAN BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 31 JAPAN BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 32 CHINA BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 33 CHINA BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 34 INDIA BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 35 INDIA BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 36 AUSTRALIA BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 37 AUSTRALIA BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 38 SOUTH KOREA BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 39 SOUTH KOREA BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 42 REST OF WORLD BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 43 REST OF WORLD BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 44 REST OF WORLD BRAIN IMAGING AND NEUROIMAGING MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 45 MIDDLE EAST BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 46 MIDDLE EAST BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 47 AFRICA BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 48 AFRICA BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
TABLE 49 LATIN AMERICA BRAIN IMAGING AND NEUROIMAGING MARKET, BY IMAGING TYPE, 2018-2032 (USD BILLION)
TABLE 50 LATIN AMERICA BRAIN IMAGING AND NEUROIMAGING MARKET, BY END USER, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BRAIN IMAGING AND NEUROIMAGING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BRAIN IMAGING AND NEUROIMAGING MARKET
FIGURE 4 GLOBAL BRAIN IMAGING AND NEUROIMAGING MARKET, SHARE (%), BY IMAGING TYPE, 2022
FIGURE 5 GLOBAL BRAIN IMAGING AND NEUROIMAGING MARKET, SHARE (%), BY END USER, 2022
FIGURE 6 GLOBAL BRAIN IMAGING AND NEUROIMAGING MARKET, SHARE (%), BY REGION, 2022
FIGURE 7 NORTH AMERICA: BRAIN IMAGING AND NEUROIMAGING MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 EUROPE: BRAIN IMAGING AND NEUROIMAGING MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 ASIA-PACIFIC: BRAIN IMAGING AND NEUROIMAGING MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 REST OF THE WORLD: BRAIN IMAGING AND NEUROIMAGING MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 GLOBAL BRAIN IMAGING AND NEUROIMAGING MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 12 GE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 GE: SWOT ANALYSIS
FIGURE 14 SIEMENS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 SIEMENS: SWOT ANALYSIS
FIGURE 16 CANON: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 CANON: SWOT ANALYSIS
FIGURE 18 HITACHI MEDICAL SYSTEMS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 HITACHI MEDICAL SYSTEMS: SWOT ANALYSIS
FIGURE 20 MEDTRONIC PLC..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 MEDTRONIC PLC..: SWOT ANALYSIS
FIGURE 22 EB NEURO S.P.A.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 EB NEURO S.P.A.: SWOT ANALYSIS
FIGURE 24 NEUROSOFT: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 NEUROSOFT: SWOT ANALYSIS
FIGURE 26 MINFOUND MEDICAL SYSTEMS CO. LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 MINFOUND MEDICAL SYSTEMS CO. LTD.: SWOT ANALYSIS
FIGURE 28 ELEKTA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 ELEKTA: SWOT ANALYSIS
FIGURE 30 VARIAN MEDICAL SYSTEMS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 VARIAN MEDICAL SYSTEMS: SWOT ANALYSIS
FIGURE 32 GENERAL ELECTRIC COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 GENERAL ELECTRIC COMPANY: SWOT ANALYSIS
FIGURE 34 PHILIPS HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 PHILIPS HEALTHCARE: SWOT ANALYSIS
FIGURE 36 TOSHIBA MEDICAL SYSTEMS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 TOSHIBA MEDICAL SYSTEMS: SWOT ANALYSIS
FIGURE 38 SANRAD MEDICAL SYSTEMS PVT. LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 39 SANRAD MEDICAL SYSTEMS PVT. LTD: SWOT ANALYSIS
FIGURE 40 ESAOTE SPA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 ESAOTE SPA: SWOT ANALYSIS
